FDA declines to review Moderna application for new flu vaccine

The Guardian - World NewsEN 3 min read 100% complete by Melody SchreiberFebruary 11, 2026 at 12:40 AM

AI Summary

medium article 3 min

The FDA has declined to review Moderna's application for a new mRNA flu vaccine, despite previously signaling approval for the project. The FDA's decision stems from concerns that Moderna's clinical trials compared the new shot to standard flu shots instead of high-dose vaccines for high-risk individuals, deeming the trials inadequate. Moderna did compare their vaccine against an existing high-dose flu shot in adults ages 65 and older. Experts worry this decision could discourage future investment in innovative influenza vaccines and create uncertainty for vaccine development. While Moderna's trials showed the new vaccine elicited better antibody responses than existing vaccines, the FDA issued a refusal-to-file letter, requiring more information before considering the application.

Key Entities & Roles

Key Player Opposition Context

UC Law San Francisco 40% Center for Biologics Evaluation and Research 45% Vinay Prasad 50% Dorit Reiss ×260% Donald Trump 60% United States ×270% United States Food and Drug Administration ×485% Moderna ×690%

Keywords

flu vaccine 100% fda 90% mrna vaccine 80% clinical trials 70% moderna 70% vaccine regulation 60% refusal-to-file letter 60% standard of care 50% antibody responses 40%

Sentiment Analysis

Negative

Score: -0.40

Source Transparency

Source

The Guardian - World News

Classification Confidence

90%

Geographic Perspective

United States

This article was automatically classified using rule-based analysis.

Topic Connections

Explore how the topics in this article connect to other news stories

No topic relationship data available yet. This graph will appear once topic relationships have been computed.

flu vaccine fda mrna vaccine clinical trials moderna vaccine regulation refusal-to-file letter standard of care antibody responses

Explore Full Topic Graph

Find Similar Articles

AI-Powered

Discover articles with similar content using semantic similarity analysis.